RUNX1T1 is collectively viewed as a biomarker for primary pancreatic endocrine tumors (PETs), breast cancer, and colorectal cancer (CRC) and a strong indicator of patient prognosis [51, 54, 55]. The gene discussed is RUNX1T1; the disease is breast cancer.